Esra Arslan Aksu, Demet Yalcin Kehribar


The Covid-19 pandemic has caused many people to die all over the world. Isolation rules are not enough to control the epidemic, and the most important solution for returning to normal life is vaccination. In our study, data on vaccination rates and clinical courses in hospitalized patients were examined and results regarding the effectiveness of the vaccine were obtained. Vaccination rates and prognoses of patients receiving inpatient treatment with the diagnosis of Covid-19 in our pandemic clinics were investigated. 316 patients who were followed up in the clinic were examined. Among these patients, 77 (24.4%) patients were found to be vaccinated. It was determined that 239 patients (75.6%) were not vaccinated. The mean age was 41.6±5 in vaccinated patients and 24.4±4 in unvaccinated patients. While being followed in the clinic, 65 of the 78 patients who were taken to the intensive care unit were unvaccinated and 13 were vaccinated. No one died among those who were vaccinated. As a result of our study, it was determined that the vaccine reduced the rate of hospitalization significantly, similar to other studies. In addition, it has been observed that the vaccine has positive effects on the mortality and morbidity of the patients followed in the intensive care unit.

Article visualizations:

Hit counter


Covid-19, pandemic, vaccine, mortality, morbidity

Full Text:



Adams, M. L., Katz, D. L., & Grandpre, J. (2020). Population-based estimates of chronic conditions affecting risk for complications from coronavirus disease, United States. Emerging infectious diseases, 26(8), 1831.

Biggs, A. T., & Littlejohn, L. F. (2021). Revisiting the initial COVID-19 pandemic projections. The Lancet Microbe, 2(3), e91-e92

Carrillo-Vega, M. F., Salinas-Escudero, G., García-Peña, C., Gutiérrez-Robledo, L. M., & Parra-Rodríguez, L. (2020). Early estimation of the risk factors for hospitalization and mortality by COVID-19 in Mexico. PLoS One, 15(9), e0238905.

Corey, L., Mascola, J. R., Fauci, A. S., & Collins, F. S. (2020). A strategic approach to COVID-19 vaccine R&D. Science, 368(6494), 948-950.

Garg, S., Kim, L., Whitaker, M., O’Halloran, A., Cummings, C., Holstein, R., & Fry, A. (2020). Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 COVID-NET, 14 States, March 1–30, 2020. Morbidity and mortality weekly report, 69(15), 458.

Hodgson, S. H., Mansatta, K., Mallett, G., Harris, V., Emary, K. R., & Pollard, A. J. (2021). What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2. The lancet infectious diseases, 21(2), e26-e35.

Voysey, M., Clemens, S. A. C., Madhi, S. A., Weckx, L. Y., Folegatti, P. M., Aley, P. K., & Bijker, E. (2021). Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. The Lancet 397(10269): 99-111.

World Health Organization. (2020). Coronavirus disease (COVID-2019) press briefings. Geneva: World Health Organization.

DOI: http://dx.doi.org/10.46827/ejphs.v4i2.105


  • There are currently no refbacks.

Copyright (c) 2021 Esra Arslan Aksu, Demet Yalcin Kehribar

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2019 - 2023. European Journal of Public Health Studies (ISSN 2668-1056/ISSN-L 2668-1056) is a registered trademark of Open Access Publishing Group. All rights reserved.

This journal is a serial publication uniquely identified by an International Standard Serial Number (ISSN) serial number certificate issued by Romanian National Library. All the research works are uniquely identified by a CrossRef DOI digital object identifier supplied by indexing and repository platforms. All the research works published on this journal are meeting the Open Access Publishing requirements and standards formulated by Budapest Open Access Initiative (2002), the Bethesda Statement on Open Access Publishing (2003) and Berlin Declaration on Open Access to Knowledge in the Sciences and Humanities (2003) and can be freely accessed, shared, modified, distributed and used in educational, commercial and non-commercial purposes under a Creative Commons Attribution 4.0 International License. Copyrights of the published research works are retained by authors.